Cell and gene therapy venture capital and public funding deal value
STO-REC-STAT01M2KJT3 Research
3.4 billionUSD
Global · 2023
Cell and gene therapy venture capital and public funding deal value worldwide stood at 3.4 billion USD in 2023 (IQVIA).
- Publisher
- IQVIA
- Authority tier
- T3 Research
- Locator
- Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023
- Retrieved
- 15 Sep 2026
- Status
- Verified
What the source says
Following historic funding levels in 2021 and a retraction in 2022, nearly 100 deals and $3.4Bn of deal value occurred in 2023.
Verbatim extraction verified: The figure 3.4 billion USD is directly attested in the quoted passage (Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023).
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH
- MLA
- IQVIA Institute. "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH.
- Chicago
- IQVIA Institute. "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH.
- BibTeX
- @misc{iqvia2023cellkt7nnh, author = {{IQVIA Institute}}, title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Chain of Custody · Verification Audit
Primary Source
- Publisher
- IQVIA Institute · homepage ↗
- Authority tier
- Tier 3 · Industry & Research
- Report
- Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios
- Type
- Press release
- Published
- —
- Locator
- Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023
- Retrieved
- 15 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 15 September 2026
- Last revision
- 15 September 2026
- Archival URI
- /stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH